← Back to DCF

Breakdown · AZN.L

AstraZeneca

WACC
FCF PROJECTION
SENSITIVITY
PER-YEAR CASH FLOWS
Year CF Discount factor PV Cumulative PV
1 381.93 0.9355 357.30 357.30
2 405.64 0.8752 355.00 712.30
3 430.82 0.8187 352.72 1065.02
4 457.56 0.7659 350.45 1415.47
5 485.96 0.7165 348.20 1763.67
6 516.12 0.6703 345.96 2109.63
7 548.16 0.6271 343.74 2453.37
8 582.18 0.5866 341.53 2794.90
9 618.32 0.5488 339.33 3134.23
10 656.70 0.5134 337.15 3471.38
11 673.12 0.4803 323.29 3794.67
12 689.94 0.4493 310.00 4104.67
13 707.19 0.4203 297.26 4401.93
14 724.87 0.3932 285.04 4686.97
15 742.99 0.3679 273.32 4960.29
16 761.57 0.3441 262.09 5222.38
17 780.61 0.3219 251.31 5473.69
18 800.12 0.3012 240.98 5714.67
19 820.13 0.2818 231.08 5945.75
20 840.63 0.2636 221.58 6167.32
REVERSE DCF

At $13858.00, the market implies a stage-1 growth rate of 17.7%.

MARKET IMPLIES
17.7%
YOUR ASSUMPTION
6.2%
DELTA
+11.5pp

If $13858.00 is correct and your other inputs (WACC 6.9%, 10+10y, terminal 2.5%) hold, the market needs AZN.L to grow cash flow at 17.7% annually for the next 10 years.